Table 1.

Top-line HCP survey findings of current approaches to dietary management of CMA from the MENAP region.

First Line

eHF (53%) is selected first line by HCPs to manage mild-to-moderate IgE- and non-IgE-mediated CMA. Poor palatability and formula acceptance were the most frequent challenges faced by patients utilizing AAF and eHF. Lack of efficacy was the most frequent challenge faced by patients utilizing pHF-W to feed children with confirmed CMA. Nearly all (97%) respondents indicated that patients at least sometimes switch from a first-line formula; 68% of HCPs indicated that patients “sometimes” make the switch, 24% indicated this happens “often”, and 5% indicated “very often”.

Second Line

49% of HCPs initiated AAF and 41% of HCPs initiated pHF-W second line to manage mild-to-moderate CMA. HCPs indicated challenges with formula acceptance in patients utilizing eHF and issues with affordability/cost. 69% of HCPs indicated that patients “sometimes” switch from a second-line formula, 14% “often” make this switch, while 14% “never” switch.

AAF, amino acid formula; CMA, cow’s milk allergy; eHF, extensively hydrolyzed casein/whey formula; HCP, healthcare professional; Ig, immunoglobulin; pHF-W, partially hydrolyzed whey formula.